Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O.

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

PLOS MEDICINE 2013. 10(9): . Nº de citas: 280

[doi:10.1371/journal.pmed.1001510]

Gutiérrez C, Hernández-Novoa B, Vallejo A, Serrano-Villar S, Abad-Fernández M, Madrid N, Díaz L, Moreno A, Dronda F, Zamora J, Muñoz-Fernández MA, Moreno S.

Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials

AIDS 2013. 27(13): 2081-2088. Nº de citas: 13

[doi:10.1097/QAD.0b013e328361d0e1]

Hernando V, Alejos B, Monge S, Berenguer J, Anta L, Vinuesa D, Palacios R, Muga R, Moreno S, Jarrin I.

All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010

BMC INFECTIOUS DISEASES 2013. 13: 382-382. Nº de citas: 18

[doi:10.1186/1471-2334-13-382]

Serrano-Villar S, Quereda C, Moreno A, Pérez-Elías MJ, Casado JL, Royuela A, Dronda F, Navas E, Hermida JM, Moreno S.

Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections

CLINICAL INFECTIOUS DISEASES 2013. 57(3): 458-464. Nº de citas: 4

[doi:10.1093/cid/cit221]

Wikman P, Safont P, Del Palacio M, Moreno A, Moreno S, Casado JL.

The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients

NEPHROLOGY DIALYSIS TRANSPLANTATION 2013. 28(8): 2073-2081. Nº de citas: 20

[doi:10.1093/ndt/gft210]

Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R.

Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment

ACTA TROPICA 2013. 127(2): 101-104. Nº de citas: 30

[doi:10.1016/j.actatropica.2013.04.003]

Holguín A, Norman F, Martín L, Mateos ML, Chacón J, López-Vélez R, Pérez-Molina JA.

Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.

CLINICAL AND VACCINE IMMUNOLOGY 2013. 20(8): 1197-1202. Nº de citas: 19

[doi:10.1128/CVI.00221-13]

Savini H, Gautret P, Gaudart J, Field V, Castelli F, López-Vélez R, Lim PL, Shaw M, von Sonnenburg F, Loutan L, Simon F.

Travel associated Diseases, Indian Ocean Islands, 1997-2010

EMERGING INFECTIOUS DISEASES 2013. 19(8): 1297-1301. Nº de citas: 19

[doi:10.3201/eid1908.121739]

Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, SPRING-1 Team.

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.

AIDS 2013. 27(11): 1771-1778. Nº de citas: 144

[doi:10.1097/QAD.0b013e3283612419]

Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H, BENCHMRK Study Teams.

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.

The Lancet. Infectious diseases 2013. 13(7): 587-596. Nº de citas: 114

[doi:10.1016/S1473-3099(13)70093-8]

Casado JL.

Liver Toxicity in HIV-Infected Patients Receiving Novel Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors Etravirine and Rilpivirine

AIDS REVIEWS 2013. 15(3): 139-145. Nº de citas: 17

Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA.

Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies

AIDS 2013. 27(10): 1641-1655. Nº de citas: 9

[doi:10.1097/QAD.0b013e3283601199]

Sainz T, Serrano-Villar S, Díaz L, González Tomé MI, Gurbindo MD, de José MI, Mellado MJ, Ramos JT, Zamora J, Moreno S, Muñoz-Fernández MA.

The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults

AIDS 2013. 27(9): 1513-1516. Nº de citas: 140

[doi:10.1097/QAD.0b013e32835faa72]

Díez-Aguilar M, Ruiz-Garbajosa P, Fernández-Olmos A, Guisado P, Del Campo R, Quereda C, Cantón R, Meseguer MA.

Non-diphtheriae Corynebacterium species: an emerging respiratory pathogen

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2013. 32(6): 769-772. Nº de citas: 65

[doi:10.1007/s10096-012-1805-5]

Gasch O, Camoez M, Domínguez MA, Padilla B, Pintado V, Almirante B, Lepe JA, Lagarde M, Ruiz de Gopegui E, Martínez JA, Montejo M, Torre-Cisneros J, Arnáiz A, Goenaga MA, Benito N, Rodríguez-Baño J, Pujol M.

Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2013. 68(6): 1423-1430. Nº de citas: 42

[doi:10.1093/jac/dkt016]

Berenguer J, Alvarez-Pellicer J, Carrero A, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Tural C, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Barquilla E, Bellón JM, González-García J.

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

JOURNAL OF HEPATOLOGY 2013. 58(6): 1104-1112. Nº de citas: 23

[doi:10.1016/j.jhep.2013.01.042]

Casado JL, Iglesias V, del Palacio M, Marín A, Perez-Elías MJ, Moreno A, Moreno S.

Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV 2013. 25(12): 1599-1603. Nº de citas: 5

[doi:10.1080/09540121.2013.793275]

Lo B, Grady C, Working Group on Ethics of the International AIDS Society.

Ethical considerations in HIV cure research: points to consider

CURRENT OPINION IN HIV AND AIDS 2013. 8(3): 243-249. Nº de citas: 74

[doi:10.1097/COH.0b013e32835ea1c5]